Cannabis brand 1906 said Monday it has closed an $18-million funding round led by Navy Capital.
The round was supported by the company’s current investors, several institutions and individuals.
The company said it plans to use the funds to support its launch in Illinois, Michigan and Massachusetts.
"Navy Capital's investment in 1906 reflects our belief that it is one of the best brands in the country," Sean Stiefel, a Navy Capital portfolio manager, said in a statement.
"We are very impressed with the company whose fast acting formulations represent the cutting edge of cannabis. Our investment will help 1906 become one of the leading brands in the new adult use markets of Illinois, Massachusetts and Michigan."
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
The company also announced the launch of its pressed tablets, Drops.
Drops are the only pill on the market that combines plant medicine and medicinal cannabis, the company said The tablets take effect in less than 20 minutes, according to 1906.
Photo courtesy of 1906.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
